Literature DB >> 26881768

The Changing Drug Culture: Medical and Recreational Marijuana.

Timothy E Albertson1, James A Chenoweth1, Daniel K Colby1, Mark E Sutter1.   

Abstract

The major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. There are also two synthetic pharmaceutical cannabinoids, nabilone and dronabinol, available by prescription in the United States. The use of marijuana has increased in the United States with passage of medical marijuana laws in many states and legalization of recreational marijuana use in several states. In addition, the potency of marijuana has increased in recent years. Marijuana has been used for a variety of medical purposes, including management of nausea and vomiting, appetite and immunologic stimulation in patients with HIV infection and AIDS, glaucoma, neurologic disorders, and pain relief. Studies on the benefits of marijuana as a treatment for various conditions have been inconsistent, except for those on pain management. Marijuana has adverse effects, and has been associated with driving impairment, psychosis, dependence and withdrawal syndromes, hyperemesis, acute cardiac events, some cancers, and impaired lung function. As with studies on the benefits of marijuana, studies of adverse effects have yielded inconsistent results. Except for impaired driving and the occurrence of dependence and withdrawal syndromes, the adverse effects of marijuana use have not been fully studied. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26881768

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  5 in total

1.  Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder.

Authors:  Deepak Cyril D'Souza; Rajiv Radhakrishnan; Mika Naganawa; Suhas Ganesh; Nabeel Nabulsi; Soheila Najafzadeh; Jim Ropchan; Mohini Ranganathan; Jose Cortes-Briones; Yiyun Huang; Richard E Carson; Patrick Skosnik
Journal:  Mol Psychiatry       Date:  2020-09-24       Impact factor: 15.992

2.  The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of Hospitalization due to Vaso-Occlusive Crises.

Authors:  Samir K Ballas
Journal:  Cannabis Cannabinoid Res       Date:  2017-07-01

3.  Investigating the sequential patterns of methamphetamine use initiation in Iran.

Authors:  Ebrahim Moghimi Sarani; Jamshid Ahmadi; Bahare Oji; Motahareh Mahi-Birjand; Nader Bagheri; Amir Bazrafshan; Marie Dehghan Manshadi; Sajad Yaghoubi; Asiyeh Dezhkam; Mehrdad Khatami; Meghdad Abdollahpour-Alitappeh
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-07-29

4.  Prevalence and Correlates of Cannabis Use in Massachusetts after Cannabis Legalization and before Retail Sales.

Authors:  Elizabeth A Evans; Eva Goldwater; Edward J Stanek; Penny Brierley-Bowers; David Buchanan; Jennifer M Whitehill
Journal:  J Psychoactive Drugs       Date:  2020-11-26

5.  Urinary Acrylonitrile Metabolite Concentrations Before and after Smoked, Vaporized, and Oral Cannabis in Frequent and Occasional Cannabis Users.

Authors:  David L Ashley; Víctor R De Jesús; Osama A Abulseoud; Marilyn A Huestis; Daniel F Milan; Benjamin C Blount
Journal:  Int J Environ Res Public Health       Date:  2020-09-04       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.